Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL. [electronic resource]
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 11 2020
- 2803-2812.e2 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1542-7714
10.1016/j.cgh.2020.04.037 doi
Antigens, Surface--therapeutic use Antiviral Agents--therapeutic use DNA, Viral Guanine--analogs & derivatives Hepatitis B Surface Antigens Hepatitis B virus--genetics Hepatitis B, Chronic--drug therapy Humans Incidence Recurrence Tenofovir--therapeutic use Treatment Outcome